Evercore bullish on Altimmune, likes drug move into alcohol related disease
Evercore ISI likes the expansion of pemvidutide into alcohol liver disease and alcohol use disorder as it adds another leg to the pemvidutide ...
Evercore price target lowered to $306 from $400 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Evercore (EVR) to $306 from $400 and keeps an Overweight rating on the shares. The robust ...
Evercore ISI Forecasts Strong Price Appreciation for Albertsons Companies (NYSE:ACI) Stock
Albertsons Companies (NYSE:ACI – Get Free Report) had its target price lifted by research analysts at Evercore ISI from $21.00 to $22.00 in a report issued on Tuesday,Benzinga reports. The brokerage ...
Pensions & Investments3d
Private equity circling Big Ten college conference sports
Kyle Walters, a private equity analyst at PitchBook, pointed out that sponsoring all these sports can be quite expensive, and ...
Jefferies: A Bargain As Fundamentals Improve
Discover why Jefferies Financial Group is a strong buy at ~$55, with improving efficiency, diverse revenue streams, and ...